8
Participants
Start Date
August 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
November 30, 2013
Brivanib
800 mg (4 x 200 mg tablets) self-administered orally at approximate same time each day on a continuous daily schedule Days 1-14 of 14 day cycle.
Irinotecan
180 mg/m\^2 by vein on Day 1 of a 14 day cycle.
UT MD Anderson Cancer Center, Houston
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
M.D. Anderson Cancer Center
OTHER